Bayer Pharma Aktiengesellschaft

Bayer Cropscience Ag

Piramal Imaging Sa

Niels Böhnke

Reiner Fischer

Thomas Bretschneider

Andreas Turberg

Kerstin Ilg

Philip Lienau

Gerhard Siemeister

Ulf Bömer

Rolf Bohlmann

Dirk Kosemund

Arne Scholz

Olga Malsam

Ulrich Görgens

Hans-Georg Schwarz

Daniela Portz

Ulrich Lücking

Ludwig Zorn

Werner Hallenbach

Heribert Schmitt-Willich

Robert Velten

Walter Hübsch

Benjamin Bader

Norbert Schmees

Volker Schulze

Johannes Köbberling

Ingo Hartung

Julia Johanna Hahn

Anne Decor

Michael Maue

Alexander Arlt

Sebastian Horstmann

Lutz Lehmann

Mathias Berndt

Klaus Raming

Matthias Friebe

Bernard Jacques Haendler

Tobias Harschneck

Karin Horn

Andre Müller

Arnoldus Vermeer

Norman Koglin

Florian Pühler

Anne DÉCOR

The invention relates inter alia to halogen-substituted compounds of the general formula (I) in which the substituents A, R-Rand Z-Zhave the meanings given in the description. Also described are processes for preparing the compounds of the formula (I) and possible intermediates for the preparation of these compounds. The compounds according to the invention are particularly suitable for controlling insects, arachnids and nematodes in agriculture and ectoparasites in veterinary medicine.

Halogen-substituted compounds

The present invention relates to 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group of general formula (I) as described and defined herein, and methods for their preparation, their use for the treatment and/or prophylaxis of disorders, in particular of hyper-proliferative disorders and/or virally induced infectious diseases and/or of cardiovascular diseases. The invention further relates to intermediate compounds useful in the preparation of said compounds of general formula (I).

5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group

The present invention relates to N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone group of general formula (I) as described and defined herein, and methods for their preparation, their use for the treatment and/or prophylaxis of disorders, in particular of hyper-proliferative disorders and/or virally induced infectious diseases and/or of cardiovascular diseases. The invention further relates to intermediate compounds useful in the preparation of said compounds of general formula (I).

N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone group

The present invention relates to 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group of general formula (I) as described and defined herein, and methods for their preparation, their use for the treatment and/or prophylaxis of disorders, in particular of hyper-proliferative disorders and/or virally induced infectious diseases and/or of cardiovascular diseases. The invention further relates to intermediate compounds useful in the preparation of said compounds of general formula (I).

5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group

The present invention relates to disubstituted N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfoximine group of general formula (I) as described and defined herein, and methods for their preparation, their use for the treatment and/or prophylaxis of disorders, in particular of hyper-proliferative disorders and/or virally induced infectious diseases and/or of cardiovascular diseases. The invention further relates to intermediate compounds useful in the preparation of said compounds of general formula (I).

N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfoximine group

This invention relates to homoglutamic acid derivatives suitable for labeling or already labeled withF orF, methods of preparing such compounds, compositions comprising such compounds, kits comprising such compounds or compositions and uses of such compounds, compositions or kits for diagnostic imaging.

Homoglutamic acid derivatives

Growing community of inventors

Berlin, Germany

Niels Böhnke